The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival (OS) among Medicare beneficiaries receiving sipuleucel-T (sip-T) versus oral treatment for metastatic castration-resistant prostate cancer (mCRPC).
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; Bristol-Myers Squibb; Dendreon; Exelixis; Janssen; Novartis; Pfizer; Tempus
Research Funding - Bayer (Inst); Pfizer (Inst)
 
Scott C. Flanders
Employment - Dendreon
Stock and Other Ownership Interests - Johnson & Johnson
Travel, Accommodations, Expenses - Dendreon
 
Christine Ferro
Research Funding - Dendreon (Inst)
 
Kate Fitch
Research Funding - Dendreon (Inst)
 
Michael Fabrizio
Leadership - EOS Surfaces
Stock and Other Ownership Interests - EOS Surfaces, LLC; Exact Imaging; InTouch Health; Modio Health; Specialty Networks
Honoraria - Astellas Pharma; Bayer; Pfizer
Consulting or Advisory Role - Bayer; Clovis Oncology; InTouch Health; Teleflex Medical; UroGen pharma
Research Funding - Janssen
 
Michael Thomas Schweizer
Consulting or Advisory Role - Janssen
Research Funding - AstraZeneca (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Pfizer (Inst); Roche (Inst); Zenith Epigenetics (Inst)